Systemic lupus erythematosus is associated with an increased risk for pulmonary manifestations, including ILD and pulmonary hypertension.

Incurable Autoimmune Disease Systemic Lupus Erythematosus (SLE): New Genetic Findings Open Up Perspectives for Future Therapeutic Approaches Jan. 14, 2024 — Systemic lupus erythematosus (SLE ...

Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...

Just 5% of pediatric providers feel highly confident in evaluating and managing neuropsychiatric SLE in youth.

Fate Therapeutics (NASDAQ:FATE) announced that the U.S. FDA granted Regenerative Medicine Advanced Therapy designation to ...

Patient Chart Dynamix™ is an independent, data-driven service that unveils real-world patient management trends via large-scale patient chart audits. Designed to quantify practice patterns, measure ...

More than one-third of patients with systemic lupus erythematosus experience a flare after starting dialysis for end-stage renal disease, according to data published in Arthritis Care & Research.